Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-06-01
2010-10-26
Haddad, Maher M (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S329000, C530S325000, C530S326000, C530S327000, C530S328000
Reexamination Certificate
active
07820172
ABSTRACT:
Multi-domain peptides including a heparin-binding peptide sequence covalently linked to a linker sequence, which linker sequence is covalently linked to a trifunctional amino acid residue forming a branch with two arms, with substantially similar (homodimeric) cellular attachment peptide sequences covalently linked, directly or through an intermediate, to each branch arm, where the sequences are cell binding analogs of or derived from laminin or a portion of laminin. Further provided are preparations for medical devices, pharmaceutical compositions and methods of using the same.
REFERENCES:
patent: 3272204 (1966-09-01), Artandi et al.
patent: 4172128 (1979-10-01), Thiele et al.
patent: 4193138 (1980-03-01), Okita
patent: 4563350 (1986-01-01), Nathan et al.
patent: 4747848 (1988-05-01), Maini
patent: 4842575 (1989-06-01), Hoffman, Jr. et al.
patent: 5108436 (1992-04-01), Chu et al.
patent: 5197977 (1993-03-01), Hoffman, Jr. et al.
patent: 5509899 (1996-04-01), Fan et al.
patent: 5510418 (1996-04-01), Rhee et al.
patent: 5563046 (1996-10-01), Mascarenhas et al.
patent: 5608035 (1997-03-01), Yanofsky et al.
patent: 5635597 (1997-06-01), Barrett et al.
patent: 5643873 (1997-07-01), Barrett et al.
patent: 5648458 (1997-07-01), Cwirla et al.
patent: 5650234 (1997-07-01), Dolence et al.
patent: 5654276 (1997-08-01), Barrett et al.
patent: 5665114 (1997-09-01), Weadock et al.
patent: 5668110 (1997-09-01), Barrett et al.
patent: 5674977 (1997-10-01), Gariepy
patent: 5679637 (1997-10-01), Lappi et al.
patent: 5679673 (1997-10-01), Bowen et al.
patent: 5684136 (1997-11-01), Godowski
patent: 5728802 (1998-03-01), Barrett et al.
patent: 5759515 (1998-06-01), Rhodes et al.
patent: 5767234 (1998-06-01), Yanofsky et al.
patent: 5770704 (1998-06-01), Godowski
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5786322 (1998-07-01), Barrett et al.
patent: 5786331 (1998-07-01), Barrett et al.
patent: 5789182 (1998-08-01), Yayon et al.
patent: 5830851 (1998-11-01), Wrighton et al.
patent: 5830995 (1998-11-01), Shoyab et al.
patent: 5861476 (1999-01-01), Barrett et al.
patent: 5866113 (1999-02-01), Hendriks et al.
patent: 5869451 (1999-02-01), Dower et al.
patent: 5880096 (1999-03-01), Barrett et al.
patent: 5902799 (1999-05-01), Herrmann et al.
patent: 5916585 (1999-06-01), Cook et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 5945457 (1999-08-01), Plate et al.
patent: 5952474 (1999-09-01), Kayman et al.
patent: 5955588 (1999-09-01), Tsang et al.
patent: 5965532 (1999-10-01), Bachovchin
patent: 5989866 (1999-11-01), Deisher et al.
patent: 5994104 (1999-11-01), Anderson et al.
patent: 6001364 (1999-12-01), Rose et al.
patent: 6011002 (2000-01-01), Pastan et al.
patent: 6030812 (2000-02-01), Bauer et al.
patent: 6051648 (2000-04-01), Rhee et al.
patent: 6096798 (2000-08-01), Luthra et al.
patent: 6099562 (2000-08-01), Ding et al.
patent: 6120904 (2000-09-01), Hostettler et al.
patent: 6121236 (2000-09-01), Ben-Sasson
patent: 6168784 (2001-01-01), Offord et al.
patent: 6174530 (2001-01-01), Rose et al.
patent: 6174721 (2001-01-01), Innis et al.
patent: 6214795 (2001-04-01), Benjamin et al.
patent: 6217873 (2001-04-01), Rose et al.
patent: 6231600 (2001-05-01), Zhong
patent: 6231892 (2001-05-01), Hubbell et al.
patent: 6235716 (2001-05-01), Ben-Sasson
patent: 6248057 (2001-06-01), Mavity et al.
patent: 6251864 (2001-06-01), Dower et al.
patent: 6258371 (2001-07-01), Koulik et al.
patent: 6270788 (2001-08-01), Koulik et al.
patent: 6284503 (2001-09-01), Caldwell et al.
patent: 6294359 (2001-09-01), Fiddes et al.
patent: 6306165 (2001-10-01), Patnaik et al.
patent: 6309660 (2001-10-01), Hsu et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6326468 (2001-12-01), Canne et al.
patent: 6342591 (2002-01-01), Zamora et al.
patent: 6350731 (2002-02-01), Jehanli et al.
patent: 6368347 (2002-04-01), Maini et al.
patent: 6377349 (2002-04-01), Fercher
patent: 6387978 (2002-05-01), Ronan et al.
patent: 6406687 (2002-06-01), Luthra et al.
patent: 6410044 (2002-06-01), Chudzik et al.
patent: 6426332 (2002-07-01), Rueger et al.
patent: 6451543 (2002-09-01), Kochendoerfer et al.
patent: 6458889 (2002-10-01), Trollsas et al.
patent: 6491965 (2002-12-01), Berry et al.
patent: 6497729 (2002-12-01), Moussy et al.
patent: 6514534 (2003-02-01), Sawhney
patent: 6534591 (2003-03-01), Rhee et al.
patent: 6548634 (2003-04-01), Ballinger et al.
patent: 6585765 (2003-07-01), Hossainy et al.
patent: 6596699 (2003-07-01), Zamora et al.
patent: 6630580 (2003-10-01), Tsang et al.
patent: 6818018 (2004-11-01), Sawhney
patent: 6846853 (2005-01-01), Shimp
patent: 6863899 (2005-03-01), Koblish et al.
patent: 6921811 (2005-07-01), Zamora et al.
patent: 6949251 (2005-09-01), Dalal et al.
patent: 6984393 (2006-01-01), Amsden
patent: 7025990 (2006-04-01), Sawhney
patent: 7041641 (2006-05-01), Rueger et al.
patent: 7166574 (2007-01-01), Pena et al.
patent: 7241736 (2007-07-01), Hunter et al.
patent: 7414028 (2008-08-01), Zamora et al.
patent: 7468210 (2008-12-01), Zamora
patent: 7482427 (2009-01-01), Pena et al.
patent: 7528105 (2009-05-01), Pena et al.
patent: 7598224 (2009-10-01), Zamora et al.
patent: 2001/0014662 (2001-08-01), Rueger et al.
patent: 2002/0115836 (2002-08-01), Tsang et al.
patent: 2002/0160098 (2002-10-01), Zamora et al.
patent: 2003/0224996 (2003-12-01), Opperman et al.
patent: 2004/0038348 (2004-02-01), Pena et al.
patent: 2004/0068266 (2004-04-01), Delmotte
patent: 2004/0087505 (2004-05-01), Pena et al.
patent: 2004/0151764 (2004-08-01), Zamora
patent: 2005/0196425 (2005-09-01), Zamora
patent: 2005/0222394 (2005-10-01), Zamora et al.
patent: 2006/0024347 (2006-02-01), Zamora et al.
patent: 2006/0199764 (2006-09-01), Zamora et al.
patent: 2006/0205652 (2006-09-01), Zamora et al.
patent: 2008/0063622 (2008-03-01), Zamora et al.
patent: 2008/0160169 (2008-07-01), Zamora et al.
patent: 2008/0166392 (2008-07-01), Zamora et al.
patent: 2008/0227696 (2008-09-01), Takahashi et al.
patent: 2009/0111743 (2009-04-01), Takahashi
patent: 2009/0143566 (2009-06-01), Zamora et al.
patent: WO-WO00/18921 (2000-04-01), None
patent: WO-WO00/64481 (2000-11-01), None
patent: WO-WO02/04015 (2002-01-01), None
patent: WO-WO02/10221 (2002-02-01), None
patent: WO-WO02/19963 (2002-03-01), None
patent: WO-WO02/20033 (2002-03-01), None
patent: WO-02/062823 (2002-08-01), None
Healy et al. Designing biomaterials to direct biological responses. Ann N Y Acad Sci. Jun. 18, 1999;875:24-35.
Tong et al. Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons. J Biomed Mater Res, 42, 85-95, 1998.
Lu X et al Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom ..(1994) Biochem J 304: 929-936.
Yano et al. RGD motif enhances immunogenicity and adjuvanicity of peptide antigens following intranasal immunization. Vaccine. Dec. 12, 2003;22(2):237-43.
Ahmed, Asif et al., “Role of VEFGF Receptor-1 (Fit-1) in Mediating Calcium-Dependent Nitric Oxide Release and Limiting DNA Synthesis in Human Trophoblast Cells”,Lab Invest., vol. 76(6) Jun. 1977 , 779-791.
Andrades, Jose A. et al., “A Recombinant Human TGF-B1 Fusion Protein with Collagen-Binding Domain Promostes Migration, Growth, and Differentiation of Bone Marrow Mesenchymal Cells”,Experimental Cell Researchvol. 250 1999 , 485-498.
Baird, Andrew et al., “Receptor- and heparin-binding domains of basic fibroblast growth factor”,Proc. Natl. Acad. Sci., vol. 85 Apr. 1988 , 2324-2328.
Ballinger, Marcus D. et al., “Semirational design of a potent, artificial agonist of fibroblast growth factor receptors”,Nature Biotechnologyvol. 17 1999 , 1199-1204.
Binetruy-Tournaire, Roselyne et al., “Identification of a Peptide Blocking Vascular Endothelial Growth Factor (VEGF)-mediated Angiogenesis”,The EMB
Lin Xinhua
Takahashi Kazuyuki
Zamora Paul O.
BioSurface Engineering Technologies, Inc.
Haddad Maher M
Peacock & Myers, P.C.
Vilven Janeen
LandOfFree
Laminin-derived multi-domain peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Laminin-derived multi-domain peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Laminin-derived multi-domain peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4221785